CEO, ViiV Healthcare and President, Global Health, GSK, Gsk
Verified interview transcripts, podcast appearances, and direct quotes from Deborah Waterhouse, CEO, ViiV Healthcare and President, Global Health, GSK at Gsk. AI-verified speaker identity with full-text searchable transcripts.
“In low income countries we actually give our intellectual property to the medicine patent pool and they give licenses to generic manufacturers what that means is today 24 million people are on a dollar tgra based regimen.”
“no person living with HIV is Left Behind and that one day we are able to end this epidemic and fiser and shinogi are okay with that with GSK providing the orange umbrella they are because we pay them for their services.”
“our purpose is to ensure that no person living with HIV anywhere in the world is left behind and what that means is that we will find a way not just to develop great medicines but to make sure that at a global level there is access to those medicines.”
“we have a philosophy that we priced fairly wherever in the world we're operating... we give up our intellectual property through a voluntary licenses and we allow generic manufacturers to make our medicines at prices that those countries can afford... TLD is available across much of the developing world for about seven...”
Join EGPAF's Chip Lyons as he chats with with Deborah Waterhouse of Viiv Healthcare about what is on her mind at the AIDS ...
ViiV Healthcare is the world’s only pharmaceutical company dedicated exclusively to HIV, and in this episode, Ben meets its CEO, Deborah Waterhouse, to explore the company’s approach to HIV R&D and commercial success - as well as the controversies its global access strategy has attracted for its new long acting injectables. Deborah and Ben find they have much in common beyond both being Brits growing up in the 70s and 80s, from being students of the humanities choosing to make careers in health, to their favorite pop music. https://viivhealthcare.com https://www.unaids.org/en https://www.w…
Deborah Waterhouse was appointed to GSK's Corporate Executive Team on 8th January 2020. She became Chief Executive ...
Sign in to search the full transcript archive, filter by topic, and access every quote from Deborah Waterhouse.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →